IU Simon Cancer Center taking high school and college applicants for its Summer Research Program

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

INDIANA UNIVERSITY MELVIN AND BREN SIMON CANCER CENTER is seeking high school and college applicants for its 2016 Summer Research Program.

The annual program, held in partnership with the Indiana University-Purdue University Indianapolis Center for Research and Learning, places students with a mentor physician or researcher for nine weeks. Students work with faculty who are conducting studies in cancer research.

The program’s primary goal is to increase the number of underrepresented populations engaged in basic, clinical and prevention and control cancer research by providing positive and meaningful first-hand exposure to those fields. Each student receives a stipend of $3,200 and is responsible for their own housing and transportation arrangements.

The program allows students to interact with any of the cancer center’s research programs, shared facilities and investigators; gain exposure to a wide range of basic science, translational and clinical research activities; and attend weekly career development workshops related to gaining admission to graduate and professional programs of study.

Students are selected based on interest in biomedical or behavioral science, academic performance and personal interviews. High school students who participate must have completed at least their junior year and have maintained a grade point average of at least 3.0 on a 4.0 scale. Undergraduates in the program must have completed 24 hours of college credit, be majoring in a biomedical or behavioral science, and have maintained a grade point average of at least 3.2.

The application deadline is Feb. 26, 2016. Those students selected as finalists will be invited to campus for an interview in April 2016.

Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login